Cris Constantinescu (University of Nottingham, Queen’s Medical Centre, UK), our Editor-in Chief of European Neurological Review, discusses the background and findings of his presentation comparing the immunomodulatory activity of mesenchymal stem cells from patients with secondary progressive multiple sclerosis (SPMS) and healthy volunteers against autologous immune cells (abstract available here).
Study support: Multiple Sclerosis Society of Great Britain and Northern Ireland.
Speaker disclosure: Cris Constantinescu has nothing to disclose in relation to this video interview.
Filmed at the American Academy of Neurology (AAN) Annual Meeting 2018, Los Angeles, CA, US, April 2018.
